[The drug treatment of the Lambert-Eaton myasthenic syndrome].
Danilov
A F
AF
Sechenov Institute of Evolutional Physiology and Biochemistry, Russian Academy of Medical Sciences, St. Petersburg, Russia.
D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D000631:Aminopyridines / Q000009:adverse effects / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015624:Lambert-Eaton Myasthenic Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D009930:Organic Chemicals
D000276:Adjuvants, Immunologic; D000631:Aminopyridines; D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents; D009930:Organic Chemicals; C404023:immunomodulin